UiPath Inc. (NYSE:PATH) Stock Position Boosted by Occudo Quantitative Strategies LP

Occudo Quantitative Strategies LP lifted its position in UiPath Inc. (NYSE:PATH) by 3.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 108,166 shares of the company’s stock after buying an additional 3,204 shares during the period. Occudo Quantitative Strategies LP’s holdings in UiPath were worth $1,375,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Vanguard Group Inc. grew its position in UiPath by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 46,664,124 shares of the company’s stock worth $593,101,000 after buying an additional 576,458 shares during the last quarter. Senvest Management LLC boosted its holdings in shares of UiPath by 29.2% during the fourth quarter. Senvest Management LLC now owns 14,074,783 shares of the company’s stock worth $178,890,000 after purchasing an additional 3,180,300 shares during the period. AQR Capital Management LLC grew its holdings in shares of UiPath by 45.3% during the 4th quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company’s stock valued at $84,209,000 after acquiring an additional 2,072,089 shares in the last quarter. Norges Bank purchased a new position in UiPath in the fourth quarter valued at about $71,191,000. Finally, Jacobs Levy Equity Management Inc. grew its position in UiPath by 35.6% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company’s stock worth $69,385,000 after acquiring an additional 1,432,569 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

Insider Activity

In other UiPath news, CFO Ashim Gupta sold 98,795 shares of UiPath stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $12.01, for a total value of $1,186,527.95. Following the transaction, the chief financial officer now owns 987,322 shares of the company’s stock, valued at approximately $11,857,737.22. The trade was a 9.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Hitesh Ramani sold 12,500 shares of the company’s stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $10.19, for a total transaction of $127,375.00. Following the completion of the transaction, the chief accounting officer now owns 314,891 shares of the company’s stock, valued at $3,208,739.29. This trade represents a 3.82% decrease in their position. The disclosure for this sale can be found here. 22.37% of the stock is owned by company insiders.

UiPath Stock Performance

Shares of NYSE:PATH opened at $13.26 on Wednesday. The company has a 50 day moving average price of $11.13 and a two-hundred day moving average price of $12.71. The company has a market capitalization of $7.31 billion, a PE ratio of -82.88 and a beta of 1.01. UiPath Inc. has a 52 week low of $9.38 and a 52 week high of $20.95.

Analyst Ratings Changes

A number of research analysts recently issued reports on PATH shares. Morgan Stanley lowered their target price on shares of UiPath from $16.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 13th. UBS Group decreased their price objective on UiPath from $14.00 to $10.00 and set a “sell” rating on the stock in a report on Thursday, March 13th. BMO Capital Markets dropped their target price on shares of UiPath from $16.00 to $11.50 and set a “market perform” rating for the company in a research report on Friday, March 14th. Mizuho reduced their price objective on UiPath from $12.00 to $11.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 15th. Finally, Wells Fargo & Company decreased their price target on shares of UiPath from $13.00 to $11.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $12.72.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.